Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission
Evelyn M. Rodriguez(Health Resources and Services Administration), I. Celine Hanson(Baylor College of Medicine), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Karen Green(University of Illinois Chicago), Bei‐Hung Chang(University of Illinois Chicago), Mary Glenn Fowler(Johns Hopkins University), Clemente Díaz(University of Puerto Rico System), Harold E. Fox(George Washington University), Vincent L. Smeriglio(National Institute on Drug Abuse), Sheldon H. Landesman(SUNY Downstate Health Sciences University), Kenneth Rich(University of Illinois Chicago)
Cited by 181
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697